NOVEMBER 15, 2011
Lung Cancer Progress: 2011
Edward Garon, MD
Lung cancer is a very common malignancy. Treatments are currently available for patients with all stages of disease, and much research is also being conducted to improve on currently available therapies. This talk discusses currently available therapies, including surgery, chemotherapy and radiation therapy. Newer, targeted therapies have recently entered clinical practice. These advances are discussed, as well as clinical trials available at UCLA applying these types of approaches. Clinical trials often provide opportunities for patients to advance the science of lung cancer and to participate in trials of medications at an early stage of development.
Edward Garon, MD, is the Director of the Medical Oncology Program in Thoracic Malignancies, Assistant Professor of Medicine, Division of Hematology/Oncology, at the David Geffen School of Medicine at UCLA. Dr. Garon has published both laboratory and clinical research. Dr. Garon focuses on translating developments in the laboratory into clinical studies, and eventually clinical practice. He is conducting several clinical studies. He actively sees patients with lung cancer, thus he understands the importance of quickly moving research forward.
Edward Garon, MD
Time
7:00 p.m. - 9:00 p.m.
Schedule
7:00 - 7:15
Arrival & Refreshments
7:15 - 7:30
Anne Coscarelli, Ph.D
Introduction to Center
7:25 - 7:30
Anne Coscarelli, Ph.D.
Speaker Introduction
7:30 - 8:55
Speaker Presentation
Q&A
8:55 - 9:00
Closing
Place
Ronald Reagan UCLA Medical Center (RRMC) Auditorium,
B Level, Room B130, 757 Westwood Plaza, Los Angeles, CA 90095
Cost
Free and Open to the Public
Parking
Available at the Medical Plaza or Ronald Reagan Medical Center lots for $11.00